---
figid: PMC7260582__gr1
figtitle: Action of cetuximab, encorafenib and binimetinib
organisms:
- Homo sapiens
pmcid: PMC7260582
filename: gr1.jpg
figlink: pmc/articles/PMC7260582/figure/f0005/
number: F1
caption: Mechanism of action of cetuximab, encorafenib and binimetinib. BRAF is a
  member of the RAF kinases group. RAF kinases generally promote the activation of
  the MAPK signaling pathway after the activating signal from RAS. In turn, RAF kinases
  activate by phosphorylation MEK 1 and MEK 2 (MEK kinases) that finally sustain ERK1
  and ERK2 (ERK kinases) activation, resulting in phosphorylation of various cellular
  substrates with pivotal roles in cell survival and proliferation.
papertitle: Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal
  Cancer.
reftext: Giandomenico Roviello, et al. Transl Oncol. 2020 Sep;13(9):100795.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9344872
figid_alias: PMC7260582__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7260582__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7260582__gr1.html
  '@type': Dataset
  description: Mechanism of action of cetuximab, encorafenib and binimetinib. BRAF
    is a member of the RAF kinases group. RAF kinases generally promote the activation
    of the MAPK signaling pathway after the activating signal from RAS. In turn, RAF
    kinases activate by phosphorylation MEK 1 and MEK 2 (MEK kinases) that finally
    sustain ERK1 and ERK2 (ERK kinases) activation, resulting in phosphorylation of
    various cellular substrates with pivotal roles in cell survival and proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - IL6
  - SOS1
  - EGF
  - EGFR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - STAT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - Encorafenib
  - Binimetinib
---
